Posterior Maxillary Ridge Augmentation With Sinus Lift Using Mineralized Plasmatic Matrix Versus Autogenous Bone Graft (MPM)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03014388 |
Recruitment Status : Unknown
Verified December 2016 by Refaat Ragab Abu Ellill, Cairo University.
Recruitment status was: Not yet recruiting
First Posted : January 9, 2017
Last Update Posted : January 9, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Bone Resorption | Other: autogenous bone Other: Mineralized plasmatic matrix | Not Applicable |
To study the effectiveness of MPM in ridge augmentation with implant insertion compared with autogenous bone graft.
-PICO Population(P) : Patients with defective posterior maxillary alveolar ridge. Intervention (I) :Implant placement and ridge augmentation with MPM. Comparator (C) : Autogenous bone graft. Outcome (O) : Patient satisfaction - Implant stability.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 20 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Posterior Maxillary Ridge Augmentation With Sinus Lift Using Mineralized Plasmatic Matrix Versus Autogenous Bone Graft (A Randomized Clinical Trial Comparative Study) |
Study Start Date : | January 2017 |
Estimated Primary Completion Date : | September 2017 |
Estimated Study Completion Date : | October 2017 |
Arm | Intervention/treatment |
---|---|
Experimental: Autogenous bone graft (Gold Standard).
Patients with defective posterior maxillary alveolar ridges requiring implant insertion will have Autogenous bone graft (Gold standard) and to be used for bone augmentation with sinus lift.
|
Other: autogenous bone
Autogenous bone graft (gold standard). sinus lift with autogenous bone.
Other Name: Autobone |
Experimental: Mineralized Plasmatic Matrix (MPM)
Patients with defective posterior maxillary alveolar ridges requiring implant insertion will receive bone graft using Mineralized plasmatic matrix.
|
Other: Mineralized plasmatic matrix
By using venoud blood from the patient, together with bone graft, a centrifuge will be used to obtain the top layer after centrifuging blood at 3000 RPM.
Other Name: MPM |
- Patient Satisfaction regarding aesthetic results will be measured using questionnaire. [ Time Frame: 9 months ]outcome will be measure using questionnaire.
- Stability of dental implants. [ Time Frame: 5 months ]will be measured using OSTELL Device.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 50 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Patients systemically free.
- Patients with posterior maxillary defective ridges indicated for sinus lift procedure.
- Cases with 5 mm bone height or less are included in the study.
- Age between 18 and 50 years.
- Both sexes.
- Patients physically able to tolerate surgical and restorative procedures.
- Good oral hygiene.
- Highly motivated patients.
Exclusion Criteria:
- Patients allergic to local anesthetic agent.
- Medium and heavy smokers.
- Pregnant females.
- Presence of any pathosis in the pre-implant site.
- Presence of any mucosal disease.
- History of oral radiotherapy.
- History of prolonged steroids use.
- Psychological disorders.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03014388
Contact: refaat ragab, Master | 01111175536 | refaat.ragab.rr@gmail.com |
Principal Investigator: | Cairo University CBE | Cairo University - Ethics Committee. |
Responsible Party: | Refaat Ragab Abu Ellill, Dentist at menistry of health, Cairo University |
ClinicalTrials.gov Identifier: | NCT03014388 |
Other Study ID Numbers: |
CairoU MPM |
First Posted: | January 9, 2017 Key Record Dates |
Last Update Posted: | January 9, 2017 |
Last Verified: | December 2016 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | Evaluation of the comparative Effectiveness of MPM Augmentation in posterior maxillary ridge defects with Autogenous bone graft. |
Bone Resorption Bone Diseases Musculoskeletal Diseases |